In this episode of Hormone Insight, we delve into a major study published in The Lancet Diabetes and Endocrinology that compared the effects of semaglutide and canagliflozin as add-ons to metformin in diabetes treatment. 

For more: Semaglutide vs Canagliflozin for Type 2 Diabetes

To read the original paper